| Michael Eugene Kilkenny, MD | |
|
Us 60 At 4th Street, Store Room #6, Ceredo, WV 25507-1249 | |
| (304) 453-3050 | |
| Not Available |
| Full Name | Michael Eugene Kilkenny |
|---|---|
| Gender | Male |
| Speciality | Family Medicine |
| Location | Us 60 At 4th Street, Ceredo, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730159765 | NPI | - | NPPES |
| 0050099000 | Medicaid | WV |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 13536 (West Virginia) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Michael Eugene Kilkenny, MD Po Box 1249, Ceredo, WV 25507-1249 Ph: (304) 453-3050 | Michael Eugene Kilkenny, MD Us 60 At 4th Street, Store Room #6, Ceredo, WV 25507-1249 Ph: (304) 453-3050 |
News Archive
Idaho Technology, Inc. (ITI) has received AOAC Performance Tested Method approval for two additional Salmonella matrices—stainless steel environmental samples and dry pet food. These matrices join the list of already approved matrices in the Salmonella LT Food Security System including chocolate, cooked ham, fresh raw chicken, lettuce, raw ground beef, and liquid whole eggs. This assay uses real-time PCR technology to identify the presence of Salmonella in less than one hour after a pre-enrichment period.
PENTAX Medical Company, a healthcare industry leader in endoscopic imaging, announced the U.S. and Canadian launch of PENTAX Medical i10 Series HD+ (plus) Endoscopes, devices that provide the highest resolution HD (high definition) images ever available for colonoscopy and gastroscopy procedures that screen for and treat GI disorders.
UnitedHealthcare's Golden Rule Insurance Company has introduced new cost-effective dental and vision care coverage options for individuals and families in Alaska, Arizona, Colorado, Iowa, South Dakota and Wyoming.
Investigators in a population-based study in Denmark reporting today at the American Epilepsy Society's 65th annual meeting have found there is an increased risk of autism spectrum disorder and childhood autism in children born of mothers who are exposed to the anticonvulsant valproate during pregnancy.
Cephalon, Inc. today announced the company has received a Complete Response letter from the U.S. Food and Drug Administration (FDA) for its supplemental new drug application for NUVIGIL® (armodafinil) Tablets [C-IV] in the treatment of patients with excessive sleepiness associated with jet lag disorder resulting from eastbound travel.
› Verified 8 days ago
Eugenia M Jarrell, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1288 B Street, Ceredo, WV 25507 Phone: 304-453-3334 Fax: 304-453-2608 |